8-KAcquisitions & DispositionsRegulation FDExhibits & Filings

STRYKER CORP 8-K Report, Acquisition Completed (Apr 5, 2016)

Filed April 5, 2016For Securities:SYK

Summary

Stryker Corporation (SYK) announced the completion of its acquisition of Charger Holding Corp. on April 5, 2016. The transaction, valued at approximately $1.28 billion on a debt-free, cash-free basis, involved Merger Sub, a wholly owned subsidiary of Stryker, merging with and into Charger, with Charger continuing as a subsidiary of Stryker. This strategic move likely aims to expand Stryker's market presence and product portfolio within the medical technology sector. Investors should note that the total consideration is subject to post-closing adjustments related to working capital and other factors. The company has provided a press release detailing this significant event, which is furnished as an exhibit to this 8-K filing. This acquisition represents a substantial capital deployment for Stryker and signals an ongoing commitment to growth through strategic M&A activities.

Key Highlights

  • 1Stryker Corporation completed the acquisition of Charger Holding Corp. on April 5, 2016.
  • 2The total consideration for the acquisition was approximately $1.28 billion on a debt-free, cash-free basis.
  • 3The acquisition was structured as a merger where Charger survived as a wholly owned subsidiary of Stryker.
  • 4The deal's final cost is subject to post-closing adjustments for working capital and other items.
  • 5The completion of the merger was announced via a press release filed as an exhibit to this 8-K.
  • 6This acquisition is a significant strategic move for Stryker, indicating expansion efforts.

Frequently Asked Questions

This 8-K filing was primarily to announce and provide details on the completion of Stryker Corporation's acquisition of Charger Holding Corp.

The total consideration was approximately $1.28 billion, calculated on a debt-free and cash-free basis. This amount is subject to further adjustments.

Charger Holding Corp. was acquired by Stryker and will operate as a wholly owned subsidiary of Stryker following the merger.

Yes, the final acquisition price is subject to post-closing adjustments related to working capital and other agreed-upon terms in the merger agreement.